摘要
奶牛乳房炎(Mastitis)是奶牛最常见、最难防治、花费最多的疾病之一.奶牛乳房炎不仅给奶牛业带来极大的经济损失、制约奶牛业发展,还严重影响奶的品质和卫生,从而危及人的健康.目前控制奶牛乳房炎仍以传统的抗生素法治疗为主,但是所带来的耐药菌的产生及药残等成了更为严重的问题.而利用生物制剂防治奶牛乳房炎则具有无药残、不产生耐药、安全绿色的特点,因此愈来愈受人们的关注.本文就奶牛乳房炎生物制剂研究的最新进展进行综述.
Mastitis was one of the diseases of the most common, the most difficulty to control and most spend up to of the dairy cow. Mastitis is not only to bring the economic losses, impact of dairy industry, but also impact on the quality of milk and health of human. Antibiotic treatment is the most common convention method for treat of mastitis in dairy cow. But it could cause the more serious problem for drug-resistant of the pathogens. Biological agents have the characteristics of there is no any drug residue, side effects and safety green. So it was increasing attention more and more. This article will to summarize the latest progress of study on biological agents for prevention of dairy cow mastitis.
出处
《内蒙古民族大学学报（自然科学版）》
2009年第5期545-548,共4页
Journal of Inner Mongolia Minzu University：Natural Sciences
关键词
奶牛乳房炎
生物制剂
最新进展
Dairy cow mastitis
Biological agents
Progress
